FORS KINESITHERAPIE financials
A multi-period view of the public annual-account figures reported for FORS KINESITHERAPIE, with comparable measures and links to available source documents.
Company overviewRegistry number
1003848446
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for FORS KINESITHERAPIE
2025 versus 2024
- Operating line
- €64,106
- EBITDA
- €63,521
- Total assets
- €142,908
- Equity
- €103,138
+30.9%
+31.8%
+60.6%
+79.8%
EBITDA margin +99.1% · Equity ratio +72.2%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €64,106 | €63,521 | €142,908 | €103,138 | - |
| 202431 Dec 2024 | €48,983 | €48,203 | €88,993 | €57,364 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.